John Y. Caloz
2014
In 2014, John Y. Caloz earned a total compensation of $751K as Chief Financial Officer and Treasurer at CytRx, a 6% increase compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Option Awards | $301,000 |
| Salary | $350,000 |
| Total | $751,000 |
Caloz received $350K in salary, accounting for 47% of the total pay in 2014.
Caloz also received $100K in bonus and $301K in option awards.
Rankings
In 2014, John Y. Caloz's compensation ranked 8,778th out of 13,032 executives tracked by ExecPay. In other words, Caloz earned more than 32.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,778 out of 13,032 | 33rd |
Division Manufacturing | 3,266 out of 4,966 | 34th |
Major group Chemicals And Allied Products | 1,107 out of 1,686 | 34th |
Industry group Drugs | 881 out of 1,365 | 36th |
Industry Biological Products, Except Diagnostic Substances | 160 out of 236 | 32nd |
Source: SEC filing on May 20, 2016.
Caloz's colleagues
We found four more compensation records of executives who worked with John Y. Caloz at CytRx in 2014.
News
CytRx CEO Stephen Snowdy's 2023 pay slips 3% to $545K
August 20, 2024
CytRx CEO Stephen Snowdy receives $563K in 2022
July 28, 2023
CytRx CEO Steven Kriegsman's 2021 pay jumps 592% to $7M
June 16, 2022
CytRx CEO Steven Kriegsman's 2020 pay falls 41% to $1M
June 14, 2021
CytRx CEO Steven Kriegsman's 2019 pay jumps 68% to $1.7M
June 12, 2020
CytRx CEO Steven Kriegsman's 2018 pay falls 48% to $1M
June 26, 2019